Company Overview and News
The S&P BSE Sensex snapped its 5-day losing streak and closed in positive making a small bullish candle on the daily candlestick charts on Tuesday. The Nifty50 also held on to its crucial support level placed at 10,500 levels, but closed below its 100-days moving average placed around 10,540.
The market continues to trade on a positive note on Tuesday afternoon, with the Nifty up 11 points at 10,523 and the Sensex up 30 points at 34,646.
Mumbai: The BSE Sensex rebounded over 83 points in opening trade today, breaking its five-session losing streak on value-buying in select blue-chips amid a strengthening rupee. Overseas, most Asian shares were trading higher, tracking strong closing in the US market overnight as investors applauded easing of trade tensions between the US and China, traders said.
Order Win: Steel Strips Wheels has bagged another exports order from US Truck & Trailer aftermarket for its new truck steel wheels plant in Chennai.
Buzzing Stocks: Dabur India lost a little over 1.5 percent in the morning trade on Tuesday after agencies reported seizure of assets worth Rs 21 crore from Pradip Burman, Director of the firm.
Earnings Reaction: Share price of Dhunseri Petrochem locked at 10 percent lower circuit on the back of poor March quarter numbers.
The S&P BSE Sensex which started on a positive note on Monday failed to hold on to momentum and turned negative for the fifth consecutive day in a row. The Nifty50 which broke below its crucial support placed at 10,550 managed to hold on to 10,500 towards the close.
The market extended losses for fifth consecutive session on Monday despite positive global cues, as the Sensex fell more than 200 points amid weak midcap companies' earnings. Higher crude oil prices and weaker rupee also dented sentiment.
The market was trading flat on Monday afternoon, with the Nifty down 59 points at 10,536 and the Sensex down 152 points at 34,695.
New Delhi: Anil Kumar Jha has been appointed as the chairman-cum-managing director (CMD) of Coal India Limited, the Personnel Ministry said on Friday.
Fund Raising: Infrastructure firm NCC said its board will meet next week to consider raising funds through issuance of equity shares or warrants to promoters on preferential basis.
Market Update: The market continued trade lower, with the Sensex falling more than 100 points amid higher crude oil prices and corporate earnings.
Market Update: The market extended opening losses, continuing correction for the fourth consecutive session amid higher crude oil prices, weak rupee.
Benchmark indices extended losses for third consecutive session on Thursday, with the Sensex falling more than 200 points after Brent crude oil futures crossed USD 80 a barrel that will hit the central government's fiscal balance.
Market Closing: Benchmark indices extended losses for the second consecutive session, tracking increase in crude oil prices that will hit fiscal deficit of the country.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET